Ratio Therapeutics
Ratio Therapeutics is a pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment and monitoring. They utilize proprietary technologies, Trillium and Macropa, to create novel radiopharmaceuticals targeting high unmet needs in solid tumors. This approach addresses challenges in delivery, safety, and efficacy of traditional radiopharmaceuticals.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $50M
Date: 17-Jan-2024
Investors: Schusterman, Duquesne, PagsGroup, Bristol Myers Squibb, Center for Technology Licensing at Cornell University
Markets: Pharmaceuticals, Oncology, Radiopharmaceuticals, Biotechnology, Life Science, Medical
HQ: Boston, Massachusetts, United States
Founded: 2021
Website: https://www.ratiotx.com/
LinkedIn: https://www.linkedin.com/company/ratio-therapeutics
Twitter: https://twitter.com/Ratio_Tx
Crunchbase: https://www.crunchbase.com/organization/ratio-therapeutics
Leave a Comment
Comments
No comments yet.